Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Shayesteh R. Ferdosi(Arizona State University), Karen S. Anderson(Mayo Clinic in Arizona)
Cited by 194
Related Papers
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
|British Journal of Cancer|2011|69
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
|Breast Cancer Research and Treatment|2022|23